Search results
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 18 hours agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 21 hours agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Los Angeles· 6 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Voisard Asset Management Group Inc. Takes $86,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 14 hours agoVoisard Asset Management Group Inc. bought a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent ...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 3 days agoThis combination caused a mechanical reaction of profit squeeze, which is unlikely to be sustained as inflation stabilizes and Pfizer's revenue sources...
Moderna says its combination COVID and flu vaccine tested better than separate shots
CBS News· 5 days agoModerna announced Monday that its combination COVID and flu vaccine showed positive results in a...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Miami· 6 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Combined flu and Covid jab produces ‘higher immune response’ than separate injections
The Telegraph via Yahoo News· 5 days agoAt the moment, Moderna’s Spikevax vaccine for Covid-19 is used in the NHS booster programmes,...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 6 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...